Avecho Biotechnology P/E 2024

Avecho Biotechnology Aktienanalyse

What does Avecho Biotechnology do?

Avecho Biotechnology Ltd is a company specializing in the research of technologies to make active ingredients in the cosmetics industry more effective. The company was founded in 2008 by Dr. Timo Roiko-Jokela and is headquartered in Oxfordshire, England. Avecho's business model is based on the innovation of active ingredient technologies. The company has developed a unique technology called Invisicare® that is able to release active ingredients over a longer period of time, resulting in higher effectiveness in application. This technology also allows for better transportation of the active ingredients through the skin while protecting the skin barrier. Avecho Biotechnology has various divisions that focus on different areas of the cosmetics industry, including skincare, sunscreens, haircare, oral care, and body care. Within these divisions, the company offers various products based on the Invisicare® technology, including creamy lotions, serums, sunscreens, and shampoos. One example product from Avecho is the SolarCare range of sun care products, which are able to protect the skin from the harmful effects of UV rays while moisturizing the skin. Another example is the SkinPep range, which is specifically tailored to the needs of the skin and has high effectiveness due to its unique formula and technology. Avecho's innovations and products are utilized by a variety of cosmetics companies and brands. The company works closely with its customers to develop customized products that are tailored to their individual requirements. In recent times, Avecho has expanded its research and development efforts in the field of dermatology. The company is working to find innovative solutions for skin conditions such as psoriasis, eczema, and acne. The Invisicare® technology from Avecho is a key element in improving the effectiveness of active ingredients and protecting the skin barrier. Overall, Avecho Biotechnology is an innovative company specializing in the development of technologies and products in the cosmetics and dermatology industry. With its unique Invisicare® technology, the company provides customized solutions for the individual needs of its customers. Avecho Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Avecho Biotechnology's P/E Ratio

The Price to Earnings (P/E) Ratio of Avecho Biotechnology is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Avecho Biotechnology's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Avecho Biotechnology is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Avecho Biotechnology’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Avecho Biotechnology stock

What is the price-to-earnings ratio of Avecho Biotechnology?

The price-earnings ratio of Avecho Biotechnology is currently -2.64.

How has the price-earnings ratio of Avecho Biotechnology changed compared to last year?

The price-to-earnings ratio of Avecho Biotechnology has increased by -80.21% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Avecho Biotechnology high compared to other companies?

Yes, the price-to-earnings ratio of Avecho Biotechnology is high compared to other companies.

How does an increase in the price-earnings ratio of Avecho Biotechnology affect the company?

An increase in the price-earnings ratio of Avecho Biotechnology would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Avecho Biotechnology affect the company?

A decrease in the price-earnings ratio of Avecho Biotechnology would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Avecho Biotechnology?

Some factors that influence the price-earnings ratio of Avecho Biotechnology are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Avecho Biotechnology pay?

Over the past 12 months, Avecho Biotechnology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avecho Biotechnology is expected to pay a dividend of 0 AUD.

What is the dividend yield of Avecho Biotechnology?

The current dividend yield of Avecho Biotechnology is .

When does Avecho Biotechnology pay dividends?

Avecho Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avecho Biotechnology?

Avecho Biotechnology paid dividends every year for the past 0 years.

What is the dividend of Avecho Biotechnology?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avecho Biotechnology located?

Avecho Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avecho Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avecho Biotechnology from 6/6/1997 amounting to 0.02 AUD, you needed to have the stock in your portfolio before the ex-date on 5/14/1997.

When did Avecho Biotechnology pay the last dividend?

The last dividend was paid out on 6/6/1997.

What was the dividend of Avecho Biotechnology in the year 2023?

In the year 2023, Avecho Biotechnology distributed 0 AUD as dividends.

In which currency does Avecho Biotechnology pay out the dividend?

The dividends of Avecho Biotechnology are distributed in AUD.